A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy

Last updated: February 5, 2019
Sponsor: Dr Christopher Marguerie
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 2

Aging

Depression

Treatment

N/A

Clinical Study ID

NCT03834207
689181
  • Ages > 55
  • All Genders

Study Summary

To assess the acceptability of a personalised ICT tool that facilitates coordinated care planning, treatment optimisation and patient self-management for patients with multiple long term conditions and their team of health professionals.

Eligibility Criteria

Inclusion

PATIENTS - Inclusion Criteria:-

  • They are aged 55 or older

  • They are multimorbid patients that suffer from two or more of the following fourconditions in various disease combinations (two conditions set as the minimumthreshold):-

  • Diabetes type 2

  • Renal Failure with eGFR/GFR 30 - 59 (measured or estimated glomerular filtration rate)

  • Heart Failure in compliance with NYHA I-II (New York Heart Association classificationof heart failure)

  • Mild or moderate depression

  • They still live and generally plan on living in their home (or in the community) forthe 12-month trial duration.

  • They or their informal caregiver pass the ICT Handling Self-Check (see DeliverableD10.4, Annex 8.3) (i.e. they have access to and some familiarity with the use of ICT).

  • They, or their informal caregiver, have stable access to the internet and at least oneof the following devices readily available to use the C3-Cloud components: Computer;Notebook; Smartphone; Tablet. This includes the use of Internet Browsers to open theC3-Cloud patient dashboards online.

  • They are able to provide informed consent.

Exclusion

PATIENTS - Exclusion Criteria:-

•The exclusion criteria include almost completely the reverse of the inclusion criteria.Patients are not eligible for recruitment if:-

  • They are aged 54 or below

  • They suffer from any of the following conditions:

  • Severe Renal Failure with eGFR/GFR <30

  • Severe Heart Failure in compliance with NYHA III-IV

  • Severe depression

  • They have other debilitating conditions that impair their decision making capabilityor their life expectancy (e.g. end-of-life patients or cancer patients)

  • They or their informal caregivers do not pass the ICT Handling Self-Check (i.e. theydo not have access to suitable IT devices and do not have some familiarity with theuse of ICT).

  • They have disabilities or other health conditions that would prevent their activeinvolvement in the study project or which prevent them from carrying out essentialfunctions of the trial.

  • They live in a care institution, for instance in a residential home or nursing home.

  • Their health care expenses are covered by a private insurance: in the C3-Cloud pilotsites, private insurances have no data exchange with EHRs.

  • They do not speak the regional language: English for SWFT; Spanish for the Basquecountry; Swedish for RJH

  • They are unable to provide informed consent for study participation. Patients with further chronic diseases and other co-morbidities or symptoms, for example,frailty, sleeping problems, malnourishment or anxiety, will not be excluded fromrecruitment. Informal caregivers who pass the ICT Handling Self-Check can substitute forthe patient if the patient does not pass the ICT Handling Self-Check - the patient-informalcaregiver pair can then still be recruited. PATIENT'S HELPERS/CARERS - Exclusion Criteria:- There are no specific inclusion criteria for informal caregivers. However, the followingexclusion criteria apply:-

  • They are aged 17 or below

  • They do not have some familiarity with the use of ICT or do not have the capability tohelp the patient out with ICT usage if necessary.

  • They do not have stable access to the internet and at least one of the followingdevices readily available to use the C3-Cloud components: Computer; Notebook;Smartphone; Tablet. This includes the use of Internet Browsers to open the C3-Cloudpatient dashboards online.

  • They are not available most of the time in person or via telephone, email, SMS orother means as to respond to calls for help.

  • They have debilitating conditions that impair their decision-making capability.

  • They do not speak the local language: English for SWFT; Spanish for the Basquecountry; Swedish for RJH HEALTHCARE PROFESSIONALS - Inclusion Criteria:-

  • normally be involved in the selected patients care

  • open to new ways of working, specifically as part of a MDT (including GPs; consultantnurses or specialist nurses; district nurses; social workers; consultants;physiotherapists or pharmacists)

  • open to the use of new technology: MDT members do not have to be technologicallyknowledgeable but they should be willing to learn how to use technology to supporttheir work. HEALTHCARE PROFESSIONALS - Exclusion Criteria:-

  • None specific. Reverse of the above

Study Design

Total Participants: 672
Study Start date:
October 01, 2018
Estimated Completion Date:
April 30, 2020

Study Description

C3-CLOUD is a 4 year research project (information technology trial) funded by the EC to develop, pilot & evaluate a new clinical IT system to improve the management of elderly patients with multi-morbidity & poly-pharmacy. It will optimise patient education & self-management and foster closer collaborative working and shared decision making between healthcare professionals & patients using electronic multi-disciplinary care plans.

The main research question is - "Is the use of a personalised ICT tool that facilitates coordinated care planning, treatment optimisation and patient self-management acceptable to patients with multiple long term conditions and their team of health professionals?".

The 1st phase has focused on the development & testing of the system. The 2nd phase will involve a 12 month pilot (Feb 17-Jan 18) with max 602 patients (+/- the support of their informal care givers), and a minimum of 62 healthcare professionals in 3 European pilot sites in the UK, Sweden & Spain. An evaluation will be conducted using healthcare/treatment data & the completion of questionnaires by the study participants.

The C3-Cloud project structure is as follows:- Funded by the EC; Co-ordinated by Warwick University; 12 European partners involved, supplying technical, clinical & research expertise. These partners are based in the UK, Spain, Sweden, France, Turkey, Finland & Germany; and 3 European pilot sites involved in the study - Basque Country in Spain, Region Jamtland in Sweden and South Warwickshire in the UK.

The C3-CLOUD system consists of the following 2 integrated components. (i) C3DP - this component will be used by healthcare professionals in all 3 pilot sites to manage the care of the study patients. This system records e.g. patient identifiers, contact information, diagnoses, medication, treatments, encounters, risk factors, goals & activities for the patients etc. It also provides professionals with a clinical decision support module. (ii) a Patient Empowerment Platform (PEP) - used by patients (& carers where applicable) so that they can view & update their care plan. Patients can record information about themselves, their condition and their care, can view training materials & upload readings such as blood pressure etc. PEP also automatically takes information from the C3DP system above.

The study is aiming to recruit a minimum of 602 patients to the C3-CLOUD pilot study across all 3 pilot sites. Informed consent to participate in the study will be obtained. The patients must be aged 55+ and have at least 2 or more of the following chronic diseases - diabetes type 2, mild to moderate heart failure, moderate kidney failure and mild to moderate depression. They must also have a sufficiently high level of IT understanding and access to a suitable device/the internet, or must nominate a carer, family member or friend who does.

The patients who are recruited will receive care and treatment using the C3-CLOUD system and will have identifiable data collected about them by healthcare professionals in C3DP, and will use, and provide information about themselves, in the PEP system.

A separate cohort of max 602 patients will be identified retrospectively from local health records at the end of the study to create a 'control' group. These patients will match the same inclusion criteria. However, this control group will have no active role in the study and only their anonymised data will be utilised so that resource utilisation, medication use etc, can be compared for the two groups over the same period.

In the UK, the system will be used by a cross-section of healthcare professionals (minimum 62) across the 3 pilot sites. These will be the healthcare professionals who are most likely to be involved ordinarily in treating the patients during the study.

In addition to the clinical data captured above, the intervention group patients, their carers and the healthcare professionals involved in the project will participate in a series of system/project evaluations before, during and after the study. This will be done through anonymised questionnaires.

Healthcare utilisation & outcome data will be collected about intervention AND control group patients from local health records systems in an anonymised format. Evaluation data for the intervention group patients will also be extracted from the C3-Cloud system itself in an anonymised format.

Connect with a study center

  • Osakidetza

    Vitoria-Gasteiz, Araba 01006
    Spain

    Site Not Available

  • Region Jamtland Harjedalen

    Ostersund, S-831 27
    Sweden

    Active - Recruiting

  • South Warwickshire NHS Foundation Trust

    Warwick, Warwickshire CV34 5BW
    United Kingdom

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.